Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Salivary Gland Infection Market?
The market size for salivary gland infections has seen substantial growth over the past few years. It is forecasted to expand from $4.12 billion in 2024 to $4.46 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 8.4%. Factors contributing to this growth include the increase in oral health problems, heightened awareness about salivary disorders, a surge in bacterial and viral infections, growth in healthcare infrastructure, rise in the ageing population, and increased usage of minimally invasive treatment options.
What Growth Rate Is Forecasted for the Salivary Gland Infection Market by 2029?
The market size of salivary gland infections is expected to experience a significant spike in growth in the upcoming years, predicted to escalate to a value of $6.09 billion by 2029 with a compound annual growth rate (CAGR) of 8.1%. This surge during the forecast period is due to a number of factors such as heightened awareness of oral health, increased use of minimally invasive procedures, a rise in chronic conditions prevalence, advancements in healthcare infrastructure, and broadened patient access to specialized healthcare. Noteworthy trends expected in the forecast period encompass adopting minimally invasive procedures, advancements seen in sialendoscopy techniques, progression in imaging technologies, developments in biocompatible stent, widening use of robotic-assisted surgeries, direction of antimicrobial therapies, and the utilization of AI-driven diagnostic tools.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21281&type=smp
Which Key Companies Are Shaping the Future of the Salivary Gland Infection Market?
Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Gilead Sciences, Inc., Amgen Inc., FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Astellas Pharma Inc., Sandoz International GmbH, Vertex Pharmaceuticals Incorporated, Incyte Corporation., Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Mylan N.V., Zydus Cadila Healthcare Ltd.
Which Factors Are Driving Demand in the Salivary Gland Infection Industry?
The escalation of oral health problems is anticipated to fuel the expansion of the salivary gland infections market in the future. These health problems encompass conditions such as tooth decay, gum infections, and other oral complications. Factors contributing to the increase in these issues include poor oral hygiene, unhealthy dietary practices, and limited access to dental care. An increase in oral health problems exacerbates the risk of salivary gland infections due to the promotion of bacterial growth and obstructions in the salivary ducts. For example, the National Health Service (NHS), a government agency based in the UK, reported that in May 2024, 32.5 million dental treatments were carried out in 2022-23, demonstrating a 23.2% increase from the previous year. Consequently, the escalation in oral health problems is propelling the growth of the salivary gland infections market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21281&type=smp
How Is the Salivary Gland Infection Market Segmented by Several Divisions?
The salivary gland infection market covered in this report is segmented –
1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses
2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments
3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User
Subsegments:
1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray
2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)
3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT
4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)
5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)
6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography
7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test
What are the Emerging Market Trends Driving the Growth of the Salivary Gland Infection Industry?
Leading businesses in the salivary gland infections market are focusing on technological innovations, particularly in the field of minimally invasive procedures, to enhance treatment effectiveness, speed up patient recovery, and boost overall healthcare performance. These minimally invasive procedures, which entail smaller incisions and specialized instruments, result in less tissue impairment and more rapid healing. For example, in March 2024, Amrita Hospital, a healthcare institution based in India, initiated the Amrita Centre for minimally invasive salivary gland surgery. This centre introduced a revolutionary treatment method for salivary disorders using sialendoscopy, reducing the necessity for surgery and preserving the function of the gland. The initiation was marked by a two-day workshop where experts gave demonstrations.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/salivary-gland-infection-global-market-report
Which Regions Are Driving Growth in the Salivary Gland Infection Market?
North America was the largest region in the salivary gland infection market in 2024. The regions covered in the salivary gland infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21281
This Report Delivers Insight On:
1. How big is the salivary gland infection market, and how is it changing globally?
2. Who are the major companies in the salivary gland infection market, and how are they performing?
3. What are the key opportunities and risks in the salivary gland infection market right now?
4. Which products or customer segments are growing the most in the salivary gland infection market?
5. What factors are helping or slowing down the growth of the salivary gland infection market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model